Meeting Overview - The shareholder meeting of Anhui Wanbang Pharmaceutical Technology Co., Ltd. was held on August 21, 2025, with a total share capital of 66,261,767 shares, and 62.8712% of shares represented at the meeting [1][2] Voting Participation - A total of 4 shareholders participated in the on-site voting, representing 41,493,950 shares, which is 62.7493% of the voting shares [2] - 59 small shareholders participated through online voting, representing 165,600 shares, which is 0.2499% of the voting shares [2] Resolutions Passed - The proposal to amend the company's articles of association was approved with 99.7312% of the votes in favor, totaling 41,547,550 shares [3][4] - The proposal to revise and establish certain governance systems was also approved with 99.7369% of the votes in favor, totaling 41,549,950 shares [5][6] - The proposal to renew the audit firm for the year 2025 was approved with 99.7360% of the votes in favor, totaling 41,549,550 shares [7] Board Elections - The election of the third board of directors was conducted using cumulative voting, with 41,501,458 votes in favor, representing 99.6205% of the valid votes [8][9] - The election results for non-independent directors included Ms. Tao Chunlei and Mr. Xu Xinluo, both receiving over half of the votes [8][9] - The election results for independent directors included Mr. Zhang Hongbin and Ms. Zhuo Min, both also receiving over half of the votes [9][10] Legal Opinion - The legal opinion provided by Anhui Chengyi Law Firm confirmed that the meeting's procedures, attendance, and voting processes complied with legal and regulatory requirements [10]
万邦医药: 2025年第二次临时股东大会决议公告